Published in Cancer Weekly, March 29th, 2005
Through its Shanghai facility, the company will supply 3.6 million VScan test kits per year for a 3-year period. The contract will have a value of approximately $8,500,000 US per year with a total value of $25,500,000 US at the end of the 3 years. This contract is for the VScan HIV test kit only and does not take into account the revenue that will be generated in China by the other test kits (TB, hepatitis B&C, Dengue Fever, and malaria).
In additional news, Medical Services...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.